Autistic Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Here, we identified deletions of the NRXN1 region in affected cohorts, confirming a strong association with the autism spectrum and other neurodevelopmental disorders.
|
23472757 |
2013 |
Autistic Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Exonic deletions in NRXN1 have been associated with several neurodevelopmental disorders, including autism, schizophrenia and developmental delay.
|
23536886 |
2013 |
Autistic Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Deletions at 2p16.3 involving exons of NRXN1 are associated with susceptibility for autism and schizophrenia, and similar deletions have been identified in individuals with developmental delay and dysmorphic features.
|
23495017 |
2013 |
Autistic Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
Previous analyses of neurexin 1α (Nrxn1α) knockout (KO) mouse as a model of these disorders have revealed impairments in synaptic transmission but failed to reveal defects in social behaviour, one of the core symptoms of autism.
|
23840597 |
2013 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
MGD |
Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments.
|
19822762 |
2009 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
BEFREE |
There is evidence both for an increased burden of CNVs in schizophrenia and that risk is conferred by specific large deletions at 1q21.1 and at 15q13.2 and by deletions of NRXN1 which encodes the synaptic scaffolding protein neurexin 1.
|
19345090 |
2009 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Over the last 12 months, a series of major articles have reported associations with schizophrenia of copy number variants at 1q21, 15q11.2, 15q13.3, 16p11.2, 22q12, and Neurexin 1 loci.
|
18990708 |
2009 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
GWASCAT |
Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways.
|
31374203 |
2019 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
CTD_human |
Our findings link NRXN2 disruption to the pathogenesis of ASD for the first time and further strengthen the involvement of NRXN1 in SCZ, supporting the notion of a common genetic mechanism in these disorders.
|
21424692 |
2011 |
Schizophrenia
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Mutation of the neurexin1-gene, NRXN1, interrupting the expression of neurexin1 has been associated with schizophrenia, autism, and intellectual disability.
|
22337556 |
2012 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
All of them affect multiple genes (apart from NRXN1) and cause substantial increases in risk to develop schizophrenia (odds ratios of 2 to over 50).
|
26130694 |
2015 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
BEFREE |
We review the evidence for the role of neurexin-1α in schizophrenia and ASD, and consider how genetic disruption of neurexin-1α may underpin the neuropathology contributing to these distinct neurodevelopmental disorders.
|
21262241 |
2012 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Heterozygous copy-number variants and SNPs of CNTNAP2 and NRXN1, two distantly related members of the neurexin superfamily, have been repeatedly associated with a wide spectrum of neuropsychiatric disorders, such as developmental language disorders, autism spectrum disorders, epilepsy, and schizophrenia.
|
19896112 |
2009 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous copy-number and missense variants in CNTNAP2 and NRXN1 have repeatedly been associated with a wide spectrum of neuropsychiatric disorders such as developmental language and autism spectrum disorders, epilepsy and schizophrenia.
|
21827697 |
2011 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
However, we did not find any association with age-at-onset of schizophrenia with NRXN1 polymorphisms.
|
21477380 |
2011 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CNVs spanning the 2p16.3 (NRXN1) and the 15q11.2 gene rich region have been associated with severe neuropsychiatric disorders including schizophrenia.
|
26563496 |
2015 |
Schizophrenia
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
In both human and mice, NRXN1 is co-expressed with numerous synaptic and cell signaling genes, and known schizophrenia candidates.
|
22832527 |
2011 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We provide support for three previous findings in schizophrenia, as we identified one deletion in a case at 1q21.1, one deletion within NRXN1, and four duplications in cases and one in a control subject at 16p13.1, a locus first implicated in autism and later in schizophrenia.
|
19880096 |
2010 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Eight recurrent CNVs have reproducibly been shown to increase the risk of schizophrenia by severalfold: 22q11.2(del), 15q13.3(del), 1q21(del), 1q21(dup), NRXN1(del), 3q29(del), 7q11.23(dup), and 16p11.2(dup).
|
30144930 |
2019 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response.
|
21890328 |
2011 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Heterozygous mutations of the NRXN1 gene, which encodes the presynaptic cell-adhesion molecule neurexin-1, were repeatedly associated with autism and schizophrenia.
|
26279266 |
2015 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The overall frequency of CNVs in regions with reported associations with schizophrenia (chromosomes 1q21.1, 15q13.3, 16p11.2, and 22q11.2 and the neurexin-1 gene [NRXN1]) was similar to previous case-control studies.
|
22885689 |
2012 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, NRXN1 deletions have been reported in schizophrenia, whereas CNTNAP2 variants are associated with several neuropsychiatric phenotypes.
|
20421335 |
2010 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
However, the manner in which NRXN1 gene variation may be related to brain morphology to confer risk for ASD or schizophrenia is unknown.
|
21687627 |
2011 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
This study examined five NRXN1 single-nucleotide polymorphisms (SNPs) for possible association with the occurrence and severity of TD in 178 schizophrenia patients of European ancestry.
|
28120489 |
2017 |